SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

JSPR

Jasper Therapeutics Inc.
NASDAQHealth Care

Latest close: 0.48 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 15, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Oct 7, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Oct 5, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year249
SEC filings on record45218 flagged findings
Reported transactions (Form 4)73since Jan 25, 2023 · and 20 other holdings
Corporate events (8-K)30since Mar 11, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Jun 9, 2026).

Deadline: Nov 30, 2026

  • minimum bid price · Nasdaq, rule 5550(a)(2) · notice of Jun 3, 2026 · pending · deadline Nov 30, 2026 (text and rule agree)

The other times

Of the 30 issuers that received this notice 1 to 2 years ago, within the following 365 days 16 regained compliance, 23 did a reverse split and 1 filed a Form 25 (delisting). An issuer can be in more than one group.

Measured on our own SEC documents: the cohort is the issuers whose notices we read, not the whole market. Historical distribution, not a prediction.

Open the 8-K at the SEC

Reverse splits in 5 years

1 reverse split in 5 years (1:10 on Jan 4, 2024) · 1:10 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 452)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 15, 268-K ↗Current report · Other events new
  • Oct 14, 26S-3 ↗Securities offering new
  • Oct 9, 26PRE 14A ↗Shareholder meeting and votes
  • Oct 7, 268-K ↗Current report · Other events
  • Oct 7, 26SC TO-I ↗Merger, acquisition or tender offer
  • Oct 5, 268-K ↗Current report · Shareholder vote results
  • Oct 5, 268-K/A ↗Current report · Financial statements and exhibits · amendment
  • Oct 1, 268-K/A ↗Current report · Financial statements and exhibits · amendment
  • Sep 28, 268-K ↗Current report · A senior executive left or was appointed
  • Sep 24, 2625-NSE ↗Delisting or deregistration
  • Sep 4, 26DEF 14A ↗Shareholder meeting and votes
  • Aug 26, 268-K ↗Current report · Entered a material agreement
  • Aug 24, 26PRE 14A ↗Shareholder meeting and votes
  • Aug 17, 26SCHEDULE 13G ↗Passive stake · Velan Capital Investment Management LP · 9.9%
  • Aug 14, 268-K ↗Current report · Results
  • Aug 14, 2610-Q ↗Quarterly report
  • Insider transaction · 5 Form 4 filingsshow all 5hide
  • Aug 3, 268-K ↗Current report · Shareholder vote results
  • Jul 31, 268-K ↗Current report · Other events
  • Jul 23, 26Form 3 ↗Insider transaction
  • Jul 22, 26Form 4 ↗Insider transaction

452 filings on record, the oldest from Oct 9, 19.

Listing the 25 most recent filings of the 452 on record.

8-Ks, explained

Stress5Structure17Governance22
  • Sep 28, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Aug 26, 26StructureEntered a material agreement8-K 1.01 ↗
  • Jul 17, 26StructureSold unregistered shares+6 more in the same filing8-K 3.02 ↗
  • Jun 9, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • May 21, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jan 7, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Sep 19, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jul 9, 25StressRestructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
  • Mar 19, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jun 20, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jun 12, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Feb 6, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

12 older filings not shown · The record reaches back to Nov 25, 19.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Oct 20, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Nov 4, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • May 18, 21StressPast accounts declared unreliable and being restated8-K 4.02 ↗

The full record holds 5 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Velan Capital Investment Management LP9.9%Jul 16, 26SCHEDULE 13D/A ↗12 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • The Carlyle Group Inc.3.8%Feb 18, 26SCHEDULE 13D/A ↗10 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Velan Capital Investment Management LP9.9%Aug 17, 26SCHEDULE 13G ↗12 co-filers on this document — the figure is the largest single stake, not their sum.
  • T. Rowe Price Investment Management, Inc.7.1%Sep 30, 25SCHEDULE 13G ↗
  • Anders Hove5.3%Jan 23, 26SCHEDULE 13G/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Morgan Stanley4.8%Mar 31, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Kingdon Capital Management, L.L.C.4.7%Sep 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 4 more holdershide
  • Qiming U.S. Healthcare Fund II, L.P.3.3%Sep 30, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Integrated Core Strategies (US) LLC1.7%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Soleus Capital Management, L.P.1.0%Mar 31, 26SCHEDULE 13G/A ↗9 co-filers on this document — the figure is the largest single stake, not their sum.
  • THE GOLDMAN SACHS GROUP, INC.0.5%Mar 31, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 22, 25Buy$100KJudith Anne Shizuru↗
  • Sep 22, 25Buy$100KRON MARTELLPresident and CEO↗
  • Sep 22, 25Buy$49KSvetlana Lucas↗
  • Sep 22, 25Buy$100KTHOMAS G WIGGANS↗
  • Dec 12, 24Sell$20KJeetinder Singh MahalChief Operating Officer↗
  • Sep 12, 24Sell$19KJeetinder Singh MahalChief Operating Officer↗
  • Jun 12, 24Sell$22KJeetinder Singh MahalChief Operating Officer↗
  • Mar 12, 24Sell$24KJeetinder Singh MahalChief Operating Officer↗
  • Feb 8, 24Buy$4.5MVelan Capital Investment Management LP↗
  • Feb 8, 24Buy$2.5MCarlyle Group Inc.↗
  • Nov 28, 23Buy$6KTHOMAS G WIGGANS↗
  • Nov 21, 23Buy$6KTHOMAS G WIGGANS↗

There are 11 more transactions in this stretch.

Stock compensation, tax and giftsshow the 10 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Dec 12, 24Compensation$6KJeetinder Singh MahalChief Operating Officer↗
  • Sep 12, 24Compensation$6KJeetinder Singh MahalChief Operating Officer↗
  • Jun 12, 24Compensation$6KJeetinder Singh MahalChief Operating Officer↗
  • Jun 7, 24Compensation$2KEdwin Jonathan TuckerChief Medical Officer↗
  • Mar 12, 24Compensation$6KJeetinder Singh MahalChief Operating Officer↗
  • Oct 12, 23Tax$74KRON MARTELLPresident, CEO & Director↗
  • Oct 12, 23Tax$32KJeetinder Singh MahalChief Operating Officer↗
  • Jun 13, 23Compensation$6KJeetinder Singh MahalSee Remarks↗
  • Apr 12, 23Tax$54KJeetinder Singh MahalSee Remarks↗
  • Apr 12, 23Tax$128KRON MARTELLPresident, CEO and Director↗

The full record holds 33 transactions and goes back to Jan 25, 23.

Its sector and its market

Jasper Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Jasper Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Jasper Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
249 clean closes in the period.
SEC records
452 documents on file, from Oct 9, 2019 to Oct 15, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.